Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/74407
Título: | Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib | Autores/as: | de Vos, J. Ramos Vega, Sara Noorman, E. de Vos, P. |
Clasificación UNESCO: | 310907 Patología 320713 Oncología |
Palabras clave: | Para-Nasal Sinuses Radiation-Therapy Paranasal Sinuses Neck-Cancer Head, et al. |
Fecha de publicación: | 2012 | Publicación seriada: | Veterinary and Comparative Oncology | Resumen: | In human medicine, primary frontal sinus squamous cell carcinoma (pFS-SCC) is not frequently reported. In veterinary medicine, frontal sinus SCC is exclusively described as an extension of nasal cavity SCC. To our knowledge, this is the first publication concerning canine pFS-SCC, diagnosed using histology or cytology and medical imaging, in three dogs. The tumours extended into the orbit or brain cavity, without nasal involvement. Treatment was initiated with piroxicamcarboplatin. Prolongation of carboplatin delivery with a low dose intensity was performed on dogs with a favourable initial response. Dog 1 achieved a complete remission (CR), but was euthanized 344 days after start of therapy. Dog 2, still alive 3 years after start of therapy and in CR, received 14 carboplatin deliveries. In dog 3, after changing the treatment protocol into piroxicamtoceranib, a significant tumour reduction occurred, but the dog was euthanized after 195 days because of a relapse. | URI: | http://hdl.handle.net/10553/74407 | ISSN: | 1476-5810 | DOI: | 10.1111/j.1476-5829.2011.00292.x | Fuente: | Veterinary And Comparative Oncology [ISSN 1476-5810], v. 10 (3), p. 206-213, (Septiembre 2012) |
Colección: | Artículos |
Citas SCOPUSTM
23
actualizado el 17-nov-2024
Citas de WEB OF SCIENCETM
Citations
16
actualizado el 17-nov-2024
Visitas
162
actualizado el 27-ene-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.